Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: A randomized, placebo-controlled study

Clinical Cardiology

Volumn 27, Issue 5, 2004, Pages 295-299

  Berman, Marius ^a,c   Erman, Arie ^b   Ben Gal, Tuvia ^c   Dvir, Dan ^a   Georghiou, Georgios P ^a   Stamler, Alon ^a   Vered, Yaffa ^d,e   Vidne, Bernardo A ^a   Aravot, Dan ^a  

^a Heart Lung Transplant Unit   (Israel)

^b Inst of Nephrology and Hypertension   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

Coenzyme Q10; Heart failure; Heart transplantation

Indexed keywords

ATRIAL NATRIURETIC FACTOR; PLACEBO; TUMOR NECROSIS FACTOR; UBIDECARENONE; ULTRASOME;

ADULT; AGED; ANAMNESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG EFFECT; DYSPNEA; ECHOCARDIOGRAPHY; END STAGE HEART FAILURE; FATIGUE; FEMALE; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART SIZE; HEART TRANSPLANTATION; HUMAN; LABORATORY TEST; MALE; MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE; NEW YORK HEART ASSOCIATION CLASSIFICATION; NOCTURIA; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; WALKING; WALKING TEST;

EID: 2542523782     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960270512     Document Type: Article

References (35)

1. Lehnininger AI: Oxidation-reduction enzymes and electron transport. In Biochemistry, 2nd edition, p. 493-497. New York: Worth Publishers, 1975
2. Lowe JS, Mortom RA, Vernon J: Unsaponifiable constituents of kidney in various species. Biochem J 1957;67:228-234
3. Cunningham NF, Morton RA: Unsaponifiable constituents of liver: Ubiquinone and substance SC in various species. Biochem J 1959;72:92-99
4. Linn BO, Page AC, Wong EI, Wong AL, Gale PH, Shunk GH, Folkers K: Isolation and distribution of coenzyme Q10 in animal tissues. Am Chem Soc 1959;81:4007-4010
5. Crane FL, Hatefi Y, Lester RL, Widmer G: Isolation of a quinone from beef heart mitochondria. Biochem Biophys Acta 1957;25:220-221
6. King TE: Ubiquinone proteins and cardiac mitochondria. In Function of Quinones in Energy Conserving Systems (Ed. Trumpower BL), p. 3-25. New York: Academic Press, 1982
7. Folkers K, Littaru GP, Ho L, Runge TM, Havanonda S, Cooley D: Evidence for a deficiency of coenzyme Q10 in human heart disease. Int J Vitamin Res 1970;40:380-390
8. Littaru GP, Ho L, Folkers K: Deficiency of coenzyme Q10 in human heart disease, Part 1. Int J Vitamin Res 1972;42:291-305
9. Littaru GP, Ho L, Folkers K: Deficiency of coenzyme Q10 in human heart disease, Part 2. Int J Vitamin Res 1972;42:413-434
10. Mortensen SA: Perspectives on therapy of cardiovascular diseases with coenzyme Q10 (ubiquinone). Clin Invest 1993;71S:116-123
11. Folkers K, Baker L, Richardson PC, Shizukuishi S, Takamura K, Drzewoski J, Lewandowski J, Ellis JM: Biomedical and Clinical Aspects of Coenzyme Q, Vol. 2 (Eds. Yamamura Y, Folkers K, Ito Y), p. 449. Amsterdam: Elsevier/North Holland, 1980
12. Yamamura Y, Ishiyama T, Yamogami T, Morita Y, Ishio I, Kashiwamura S, Terader A, Tsukamoto N, Toyama S, Nakajima Y, Wada N: Clinical use of coenzyme Q for treatment of cardiovascular disease. Jpn Circ J 1967;31:168-169
13. Yamamura Y: A survey of the therapeutic uses of coenzyme Q10. In Coenzyme Q Biochemisty, Bioenergetics and Clinical Applications of Ubiquinone (Ed. Lenaz G), p. 479-507. New York: Wiley-Interscience, 1985
14. Mortensen SA, Vadhanavikit S, Baandrup U, Folkers K: Long-term coenzyme Q10 therapy: A major advance in the management of resistant myocardial failure. Drug Exp Clin Res 1985;8:581-593
15. Langsjoen PH, Vadhanavikit S, Folkers K: Effective treatment with coenzyme Q10 of patients with chronic myocardial disease. Drug Exp Clin Res 1985;8:577-579
16. Baggio E, Gandini R, Plancher AC, Passeri M, Carmosino G: Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. Molec Aspects Med 1994;15s:287-294
17. Hofman-Bang C, Rehnqvist N, Swedberg K, Wildund I, Astrom H: Coenzyme Q10 as an adjunctive in treatment of congestive heart failure. The Q10 study group. J Cardiac Fail 1995;1(2):101-107
18. Folkers K, Langsjoen P, Langsjoen PH: Therapy with coenzyme Q10 of patients in heart failure who are eligible or ineligible for a transplant. Biochem Biophys Res Comm 1992;182:247-253
19. Rector J, Cohn JN: Assessment of patient outcome with the Minnesota Living with Heart Failure Questionnaire - Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J 1992;124:1017-1025
20. Grossi G, Bargossi AM, Fiorella PL, Piazzi S: Improved high-performance liquid chromatographic method for the determination of coenzyme Q10 in plasma. J Chromat 1992;593:217-226
21. Langsjoen H, Langsjoen P, Langsjoen P, Willis R, Folkers K: Usefulness of coenzyme Q10 in clinical cardiology: A long term study. Molec Aspects Med 1994;15:165-175
22. Folkers K, Langsjoen P, Willis R, Richardson P, Xia LJ, Ye CQ, Tamagawa H: Lovastafin decreases coenzyme Q levels in humans. Proc Natl Acad Sci USA 1990;87:8931-8934
23. Langsjoen PH, Vadhanavikit S, Folkers K: Response of patients in classes 3 and 4 of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10. Proc Natl Acad Sci USA 1985;82:4240-4244
24. Digiesi V, Cantini F, Brodbeck B: Effect of coenzyme Q10 on essential arterial hypertension. Curr Ther Res Clin Exp 1990;47:841-845
25. Mortensen SA: Coenzyme Q10 as an adjunctive therapy in patients with congestive heart failure. J Am Coll Cardiol 2000;36:304-305
26. Morisco C, Trimarco B, Condorelli M: Effect of coenzyme Q10 therapy in patients with congestive heart failure: A long-term multicenter randomized study. Clin Invest 1993;71(8 suppl):s134-136
27. Watson PS, Scalia GM, Galbraith A, Burstow DJ, Bett N, Aroney CN: Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure. J Am Coll Cardiol 1999;33:1549-1552
28. Boland DJ, Abraham WT: Natriuretic peptides in heart failure. Cong Heart Fail 1998;4:23-33
29. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K: Localisation and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203
30. Kim JK, Summer SN, Durr J, Schrier RW: Enzymatic and binding effects of atrial natriuretic factor in glomeruli and nephrons. Kidney Int 1989;35:799-805
31. Steele IC, McDowell G, Moore A, Campbell NP, Shaw C, Buchanan KD, Nicholls DP: Responses of atrial natriuretic peptide and brain natriuretic peptide to exercise in patients with chronic heart failure and normal control subjects. Eur J Clin Invest 1997;27:270-276
32. Zhao SP, Zeng LF: Elevated plasma levels of tumor necrosing factor in chronic heart failure with cachexia. Int J Cardiol 1997;58:257-261
33. Milani RV, Mehra MR, Endres S, Eigler A, Cooper ES, Lavie CJ Jr, Ventura HO: The clinical relevance of circulating tumor necrosis factor alpha in acute decompensated chronic heart failure without cachexia. Chest 1996;110(4):992-995
34. Anker SD, Egerer KR, Volk HD, Kox WJ, Poole-Wilson PA, Coats AJ: Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol 1997;79(10):1426-1430
35. Landbo C, Almdal TP: Interaction between warfarin and coenzyme Q10. Ugeskr Laeger 1998;160:3226-3227